Beres Pharmaceuticals

What Beres Pharmaceuticals does

Beres Pharmaceuticals is a privately held, for-profit pharmaceutical company headquartered in Budapest, Hungary, founded in 1989. According to the available firmographic data, the company specializes in the production and distribution of pharmaceutical products, operating with a headcount in the 51-100 employee range. Its corporate website is hosted at beres-international.com, suggesting some orientation toward cross-border or export activity beyond the Hungarian domestic market, although no specific operating geographies, distribution footprint, or international subsidiary structure were disclosed in the source data.

The company's core business appears to be the manufacture and distribution of pharmaceutical products, but no product portfolio, therapeutic categories, formulation capabilities, or underlying technology stack were disclosed in the supplied information. There is no evidence in the input data regarding research and development activity, branded versus generic mix, API sourcing, manufacturing site configuration, regulatory approvals, or quality certifications. The available primary web material consisted solely of a loader/verification page with no substantive disclosures, and all other structured fields — including revenue, funding, management team, customers, partnerships, and awards — were returned empty.

The business model, pricing mechanics, go-to-market approach, and customer segmentation are not described in the source data. Given the firm's mid-sized employee count and 36-year operating history, a reasonable default assumption is a mix of domestic wholesale distribution, hospital and pharmacy channel sales, and limited export; however, this is an industry-default inference rather than a source-supported characterization. Revenue, ownership structure, and capital history are undisclosed, leaving the firm's commercial scale and capital strategy unverified.

Name

Beres Pharmaceuticals

Website

https://beres-international.com

Company type

Private

Founded year

1989

Headcount range

51–100 employees

Short description

Beres Pharmaceuticals is a privately held Hungarian pharmaceutical manufacturer and distributor headquartered in Budapest, founded in 1989 and operating with 51-100 employees focused on the production and distribution of pharmaceutical products.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Respiratory & Allergy Pharmaceuticals (HLAIAAAH)

akta.pro secondary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Pharmaceutical products
• Over-the-counter medicines
• Drug manufacturing
• Consumer healthcare
• Pharmaceutical distribution

Headquarters

HQ city

Budapest

HQ country

Hungary

HQ region

Europe

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Core offering

Beres Pharmaceuticals is a pharmaceutical manufacturer that specializes in the production and distribution of pharmaceutical products. Founded in 1989 and headquartered in Budapest, Hungary, the company employs 51-100 staff to produce and supply its pharmaceutical portfolio to its served markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical products

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Direct peers

• Egis Pharmaceuticals: Hungarian-based pharmaceutical manufacturer and distributor with a broad branded generics and specialty portfolio. Closely comparable to Beres on geography, scale tier, and integrated production-plus-distribution model.

Broad incumbents

• Gedeon Richter: Hungary's largest pharmaceutical company, operating branded, generic, and biosimilar manufacturing plus extensive CEE distribution. A larger incumbent in the exact same product/market space as Beres.
• Zentiva: Pan-European generics and OTC manufacturer with strong CEE heritage (formerly part of Sanofi). Competes head-to-head with Beres in generics distribution across Hungary and neighboring markets.
• STADA Arzneimittel: European-focused generics and OTC manufacturer-distributor with a sizable presence in CEE. Comparable to Beres in product categories and integrated supply model, though at substantially larger scale.
• Teva Pharmaceutical Industries: Global generics leader with established CEE distribution and manufacturing. Competes with Beres for Hungarian and regional pharmacy and hospital tenders, particularly in mature generic molecules.

Regional players

• KRKA: Slovenian-headquartered generics manufacturer with a strong CEE and CIS distribution footprint. Comparable in vertical integration and channel-driven model, though operating from a different home market.
• Alvogen: US-headquartered but with significant Central and Eastern European generics manufacturing and distribution operations. Overlaps with Beres in CEE generics supply and pharmacy channel relationships.
• Wörwag Pharma: German-founded specialty pharma company focused on metabolic and neurological therapy areas with CEE distribution. Comparable mid-tier player operating across similar Central European channels as Beres.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/b-res-pharmaceuticals-ltd-

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beres Pharmaceuticals